Shanrong Biotechnology Financials
| SRBT Stock | USD 1.00 0.45 81.82% |
Shanrong |
Please note, the imprecision that can be found in Shanrong Biotechnology's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Shanrong Biotechnology Corp. Check Shanrong Biotechnology's Beneish M Score to see the likelihood of Shanrong Biotechnology's management manipulating its earnings.
Shanrong Biotechnology Stock Summary
Shanrong Biotechnology competes with Embrace Change. Shanrong Biotechnology Corp. operates as a project management and executive consulting company. Shanrong Biotechnology Corp. is based in Beverly Hills, California. Shanrong Biotechnology operates under Shell Companies classification in the United States and is traded on OTC Exchange.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US81946R1077 |
| Business Address | 9350 Wilshire Boulevard, |
| Sector | Financial Services |
| Industry | Shell Companies |
| Benchmark | Dow Jones Industrial |
| Phone | 310 359 6895 |
| Currency | USD - US Dollar |
Shanrong Biotechnology Key Financial Ratios
Shanrong Biotechnology's financial ratios allow both analysts and investors to convert raw data from Shanrong Biotechnology's financial statements into concise, actionable information that can be used to evaluate the performance of Shanrong Biotechnology over time and compare it to other companies across industries.Shanrong Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Shanrong Biotechnology's current stock value. Our valuation model uses many indicators to compare Shanrong Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Shanrong Biotechnology competition to find correlations between indicators driving Shanrong Biotechnology's intrinsic value. More Info.Shanrong Biotechnology Corp is rated second in current valuation category among its peers. It also is rated second in shares outstanding category among its peers creating about 0.42 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for Shanrong Biotechnology Corp is roughly 2.40 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Shanrong Biotechnology's earnings, one of the primary drivers of an investment's value.Shanrong Biotechnology Systematic Risk
Shanrong Biotechnology's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Shanrong Biotechnology volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Shanrong Biotechnology correlated with the market. If Beta is less than 0 Shanrong Biotechnology generally moves in the opposite direction as compared to the market. If Shanrong Biotechnology Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Shanrong Biotechnology is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Shanrong Biotechnology is generally in the same direction as the market. If Beta > 1 Shanrong Biotechnology moves generally in the same direction as, but more than the movement of the benchmark.
Shanrong Biotechnology January 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Shanrong Biotechnology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Shanrong Biotechnology Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Shanrong Biotechnology Corp based on widely used predictive technical indicators. In general, we focus on analyzing Shanrong Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Shanrong Biotechnology's daily price indicators and compare them against related drivers.
| Information Ratio | 0.1105 | |||
| Maximum Drawdown | 62.0 | |||
| Value At Risk | (12.73) |
Additional Tools for Shanrong Pink Sheet Analysis
When running Shanrong Biotechnology's price analysis, check to measure Shanrong Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanrong Biotechnology is operating at the current time. Most of Shanrong Biotechnology's value examination focuses on studying past and present price action to predict the probability of Shanrong Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanrong Biotechnology's price. Additionally, you may evaluate how the addition of Shanrong Biotechnology to your portfolios can decrease your overall portfolio volatility.